117 related articles for article (PubMed ID: 32231185)
21. Spectroscopic analysis of the impact of oxidative stress on the structure of human serum albumin (HSA) in terms of its binding properties.
Maciążek-Jurczyk M; Sułkowska A
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 136 Pt B():265-82. PubMed ID: 25448930
[TBL] [Abstract][Full Text] [Related]
22. The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment ("chemobrain") involving TNF-α.
Ren X; Keeney JTR; Miriyala S; Noel T; Powell DK; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Free Radic Biol Med; 2019 Apr; 134():1-8. PubMed ID: 30593843
[TBL] [Abstract][Full Text] [Related]
23. Effects of Agaricus brasiliensis mushroom in Walker-256 tumor-bearing rats.
Jumes FM; Lugarini D; Pereira AL; de Oliveira A; Christoff Ade O; Linde GA; do Valle JS; Colauto NB; Acco A
Can J Physiol Pharmacol; 2010 Jan; 88(1):21-7. PubMed ID: 20130735
[TBL] [Abstract][Full Text] [Related]
24. Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats.
Kostenuik PJ; Orr FW; Suyama K; Singh G
Cancer Res; 1993 Nov; 53(22):5452-7. PubMed ID: 8221685
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of resistance to oxidative stress in doxorubicin resistant cells.
Furusawa S; Kimura E; Kisara S; Nakano S; Murata R; Tanaka Y; Sakaguchi S; Takayanagi M; Takayanagi Y; Sasaki K
Biol Pharm Bull; 2001 May; 24(5):474-9. PubMed ID: 11379763
[TBL] [Abstract][Full Text] [Related]
26. Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin.
Stojković S; Podolski-Renić A; Dinić J; Stanković T; Banković J; Hadžić S; Paunović V; Isaković A; Tanić N; Pešić M
Exp Cell Res; 2015 Jul; 335(2):248-57. PubMed ID: 26026740
[TBL] [Abstract][Full Text] [Related]
27. A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo.
Mookerjee A; Basu JM; Majumder S; Chatterjee S; Panda GS; Dutta P; Pal S; Mukherjee P; Efferth T; Roy S; Choudhuri SK
BMC Cancer; 2006 Nov; 6():267. PubMed ID: 17107616
[TBL] [Abstract][Full Text] [Related]
28. The influence of a thyroxine supplemented diet on selected hepatic redox equilibrium markers, liver morphology and the serum lipid profile in rats treated with doxorubicin.
Korga A; Dudka J; Burdan F; Wronecki L; Sierocinska-Sawa J; Iwan M; Korobowicz-Markiewicz A; Korobowicz E
Postepy Hig Med Dosw (Online); 2013 Mar; 67():143-9. PubMed ID: 23475490
[TBL] [Abstract][Full Text] [Related]
29. Oxidative stress and myocardial gene alterations associated with Doxorubicin-induced cardiotoxicity in rats persist for 2 months after treatment cessation.
Richard C; Ghibu S; Delemasure-Chalumeau S; Guilland JC; Des Rosiers C; Zeller M; Cottin Y; Rochette L; Vergely C
J Pharmacol Exp Ther; 2011 Dec; 339(3):807-14. PubMed ID: 21934029
[TBL] [Abstract][Full Text] [Related]
30. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
[TBL] [Abstract][Full Text] [Related]
31. Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats.
Petrovic D; Seke M; Borovic ML; Jovic D; Borisev I; Srdjenovic B; Rakocevic Z; Pavlovic V; Djordjevic A
Exp Mol Pathol; 2018 Jun; 104(3):199-211. PubMed ID: 29727604
[TBL] [Abstract][Full Text] [Related]
32. Resistance patterns of Walker carcinosarcoma 256 and other rodent tumors to cyclophosphamide and L-phenylalanine mustard.
Schmid FA; Otter GM; Stock CC
Cancer Res; 1980 Mar; 40(3):830-3. PubMed ID: 7471099
[TBL] [Abstract][Full Text] [Related]
33. Hesperidin alleviates doxorubicin-induced cardiotoxicity in rats.
Abdel-Raheem IT; Abdel-Ghany AA
J Egypt Natl Canc Inst; 2009 Jun; 21(2):175-84. PubMed ID: 21057569
[TBL] [Abstract][Full Text] [Related]
34. Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: Involvement of suppression in oxidative stress, inflammation, and apoptosis.
Zhang J; Cui L; Han X; Zhang Y; Zhang X; Chu X; Zhang F; Zhang Y; Chu L
Biomed Pharmacother; 2017 Sep; 93():1253-1260. PubMed ID: 28738542
[TBL] [Abstract][Full Text] [Related]
35. Low-dose doxorubicin with carotenoids selectively alters redox status and upregulates oxidative stress-mediated apoptosis in breast cancer cells.
Vijay K; Sowmya PR; Arathi BP; Shilpa S; Shwetha HJ; Raju M; Baskaran V; Lakshminarayana R
Food Chem Toxicol; 2018 Aug; 118():675-690. PubMed ID: 29920287
[TBL] [Abstract][Full Text] [Related]
36. Doxorubicin represses CARP gene transcription through the generation of oxidative stress in neonatal rat cardiac myocytes: possible role of serine/threonine kinase-dependent pathways.
Aihara Y; Kurabayashi M; Tanaka T; Takeda SI; Tomaru K; Sekiguchi KI; Ohyama Y; Nagai R
J Mol Cell Cardiol; 2000 Aug; 32(8):1401-14. PubMed ID: 10900167
[TBL] [Abstract][Full Text] [Related]
37. Acacia hydaspica R. Parker prevents doxorubicin-induced cardiac injury by attenuation of oxidative stress and structural Cardiomyocyte alterations in rats.
Afsar T; Razak S; Batoo KM; Khan MR
BMC Complement Altern Med; 2017 Dec; 17(1):554. PubMed ID: 29284479
[TBL] [Abstract][Full Text] [Related]
38. Experimental immunotherapy of mice with transplanted MC-rhabdomyosarcoma resistant to doxorubicin.
Berezhnaya NM; Kovalchuk EV; Vinnichuk YD; Spivak SI; Belova OB
Eksp Onkol; 2004 Mar; 26(1):63-6. PubMed ID: 15112582
[TBL] [Abstract][Full Text] [Related]
39. Walker-256 tumor growth causes oxidative stress in rat brain.
Freitas JJ; Pompéia C; Miyasaka CK; Curi R
J Neurochem; 2001 Apr; 77(2):655-63. PubMed ID: 11299328
[TBL] [Abstract][Full Text] [Related]
40. Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone.
Waki Y; Nomura M; Kasugai S; Ohya K; Miyamoto K
Cancer Res; 1999 Mar; 59(6):1219-24. PubMed ID: 10096551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
